Pediatric Hemiplegia: Synergistic Treatment Using rTMS and CIT
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01104064|
Recruitment Status : Completed
First Posted : April 15, 2010
Last Update Posted : August 19, 2013
|Condition or disease||Intervention/treatment||Phase|
|Stroke||Device: real rTMS combined with constraint induced therapy Device: sham rTMS combined with constraint induced therapy||Phase 1|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||19 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Pediatric Hemiplegia: Synergistic Treatment Using rTMS and CIT|
|Study Start Date :||February 2010|
|Actual Primary Completion Date :||August 2012|
|Actual Study Completion Date :||August 2012|
|Experimental: Real rTMS combined with CIT||
Device: real rTMS combined with constraint induced therapy
10 minutes of priming followed by 10 minutes of low-frequency is followed on the next day with constraint induced therapy. A total of 5 treatment days for each therapy is given.
|Sham Comparator: Sham rTMS combined with CIT||
Device: sham rTMS combined with constraint induced therapy
10 minutes of sham priming followed by 10 minutes of sham low-frequency is followed on the next day with constraint induced therapy. A total of 5 treatment days for each therapy is given.
- Hand function assessment [ Time Frame: Pretest, posttest ]Hand function will be assessed at pretest and posttest by a tester rating the child's performance on designated motor tasks
- cortical excitability [ Time Frame: pretest and posttest ]Cortical excitability of the primary motor cortex of the stroke hemisphere will be assessed using paired-pulse transcranial magnetic stimulation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01104064
|United States, Minnesota|
|University of Minnesota|
|Minneapolis, Minnesota, United States, 55455|
|Principal Investigator:||James R Carey, PhD, PT||University of Minnesota - Clinical and Translational Science Institute|